Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
European Urology|November 13, 2007
Early detection of prostate cancer in 2007. Part 1: PSA and PSA kineticsFritz H Schröder, H Ballentine Carter, Tineke Wolters, et al.European Urology|September 8, 2009
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancerMonique J Roobol, Ewout W Steyerberg, Ries Kranse, et al.Cancer|July 29, 2009
Anxiety and distress during active surveillance for early prostate cancerRoderick C N van den Bergh, Marie-Louise Essink-Bot, Monique J Roobol, et al.The American Journal of Surgical Pathology|November 26, 2009
False-negative prostate needle biopsies: frequency, histopathologic features, and follow-upTineke Wolters, Theodorus H van der Kwast, Cornelis J Vissers, et al.BJU International|March 18, 2011
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcomeAgnes Marije Hoogland, Anna Dahlman, Kees J Vissers, et al.The Canadian Journal of Urology|December 15, 2011
Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortalityPim J van Leeuwen, Roderick C N van den Bergh, Tineke Wolters, et al.European Urology|July 20, 2010
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic testMonique J Roobol, Fritz H Schröder, Pim van Leeuwen, et al.European Urology|November 17, 2009
Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsiesFritz H Schröder, Roderick C N van den Bergh, Tineke Wolters, et al.European Urology|October 12, 2010
Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100)Monique J Roobol, Fritz H Schröder, Geert L J H van Leenders, et al.The Journal of Urology|July 21, 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.Pageof 3